Your session is about to expire
← Back to Search
Behavioural Intervention
Aliviado Dementia Care Program for Dementia
N/A
Waitlist Available
Led By Abraham Brody, Ph.D.
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 26
Awards & highlights
Study Summary
This trial will test whether the Aliviado Dementia Care Program, specifically the Hospice Edition, can reduce the use of antipsychotics and improve quality of care for persons with dementia and their caregivers.
Who is the study for?
This trial is for English-speaking individuals over 50 with a dementia diagnosis, who are newly admitted to participating hospices post-implementation of the Aliviado program. It's not for per diem interdisciplinary team (IDT) members.Check my eligibility
What is being tested?
The HAS-QOL trial tests the Aliviado Dementia Care-Hospice Edition QAPI program against usual care in hospices. The focus is on reducing antipsychotic use and improving quality of life through team training, care plans, and caregiver education.See study design
What are the potential side effects?
Since this trial focuses on a care program rather than medication, it does not directly test drug side effects but monitors overall symptom management and quality of life improvements in dementia patients.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, month 26
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 26
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from Baseline in Monthly Percentage of Home Hospice Patients who are Prescribed Antipsychotic Medication
Change from Baseline in Monthly Percentage of Home Hospice Patients who are Prescribed Non-Opioid Analgesic Medication
Secondary outcome measures
Change from Baseline in Monthly Days of Inpatient Hospice Use
Change from Baseline in Monthly Days of Respite Care
Change from Baseline in Monthly Hours of Continuous Hospice Use
+1 moreTrial Design
8Treatment groups
Experimental Treatment
Group I: Wave 8: Usual Care for Months 1-14, Transition for Months 15-16, Intervention for Months 17-26Experimental Treatment2 Interventions
PWD at the hospice sites randomized to Wave 7 will receive usual care for 14 months, followed by the 2-month-long transition to the intervention during months 15 and 16, followed by the QAPI intervention for 9 months from Months 17-26.
Group II: Wave 7: Usual Care for Months 1-13, Transition for Months 14-15, Intervention for Months 16-26Experimental Treatment2 Interventions
PWD at the hospice sites randomized to Wave 7 will receive usual care for 13 months, followed by the 2-month-long transition to the intervention during months 14 and 15, followed by the QAPI intervention for 10 months from Months 16-26.
Group III: Wave 6: Usual Care for Months 1-12, Transition for Months 13-14, Intervention for Months 15-26Experimental Treatment2 Interventions
PWD at the hospice sites randomized to Wave 6 will receive usual care for 12 months, followed by the 2-month-long transition to the intervention during months 13 and 14, followed by the QAPI intervention for 11 months from Months 15-26.
Group IV: Wave 5: Usual Care for Months 1-11, Transition for Months 12-13, Intervention for Months 14-26Experimental Treatment2 Interventions
PWD at the hospice sites randomized to Wave 5 will receive usual care for 11 months, followed by the 2-month-long transition to the intervention during months 12 and 13, followed by the QAPI intervention for 12 months from Months 14-26.
Group V: Wave 4: Usual Care for Months 1-10, Transition for Months 11-12, Intervention for Months 13-26Experimental Treatment2 Interventions
PWD at the hospice sites randomized to Wave 4 will receive usual care for 10 months, followed by the 2-month-long transition to the intervention during months 11 and 12, followed by the QAPI intervention for 13 months from Months 13-26.
Group VI: Wave 3: Usual Care for Months 1-9, Transition for Months 10-11, Intervention for Months 12-26Experimental Treatment2 Interventions
PWD at the hospice sites randomized to Wave 3 will receive usual care for 9 months, followed by the 2-month-long transition to the intervention during months 10 and 11, followed by the QAPI intervention for 14 months from Months 12-26.
Group VII: Wave 2: Usual Care for Months 1-8, Transition for Months 9-10, Intervention for Months 11-26Experimental Treatment2 Interventions
PWD at the hospice sites randomized to Wave 2 will receive usual care for 8 months, followed by the 2-month-long transition to the intervention over months 9 and 10, followed by the QAPI intervention for 15 months from Month 11-26.
Group VIII: Wave 1: Usual Care for Months 1-7, Transition for Months 8-9, Intervention for Months 10-26Experimental Treatment2 Interventions
PWD at the hospice sites randomized to Wave 1 will receive usual care for 7 months, followed by the 2-month-long transition to the intervention over months 8 and 9, followed by the QAPI intervention for 16 Months from Month 10-26.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual Care
1990
Completed Phase 4
~7700
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
27,960,971 Total Patients Enrolled
265 Trials studying Dementia
23,579,268 Patients Enrolled for Dementia
NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
795,578 Total Patients Enrolled
16 Trials studying Dementia
22,951 Patients Enrolled for Dementia
Abraham Brody, Ph.D.Principal InvestigatorNYU Langone
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the recruitment of participants still in progress for this research endeavor?
"As detailed on clinicaltrials.gov, this trial is now closed to recruitment and hasn't been updated since November 10th 2022. However presently 396 other trials are accepting participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger